SCHEMBL270994

SCHEMBL270994

[CH2]CCC(O)C(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6395555 0.82
SCHEMBL3167427 0.81
SCHEMBL28991073 0.80 TRPV1 (0.44)
SCHEMBL29186069 0.80 LMNA (0.30)
SCHEMBL18533728 0.79 ALDH1A1 (0.39)
SCHEMBL3160911 0.76 TSHR (0.35)
SCHEMBL7631910 0.75
SCHEMBL3153259 0.75
SCHEMBL23043476 0.73
SCHEMBL331125 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070015792-A1 N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives MSD K.K. (JP) 2007-01-18 US claimed
US-5082845-A Gastrointestinal HOECHST JAPAN LIMITED (JP) 1992-01-21 US claimed
EP-0330031-B1 THERAPEUTIC AGENTS FOR THE TREATMENT OF PEPTIC ULCER DISEASE HOECHST JAPAN LIMITED (JP) 1991-12-11 EP claimed
EP-0330031-A1 Therapeutic agents for the treatment of peptic ulcer disease HOECHST JAPAN LIMITED (JP) 1989-08-30 EP claimed
US-4616020-A TREATING OBSTRUCTIVE RESPIRATORY DISEASES HOECHST AKTIENGESELLSCHAFT (DE) 1986-10-07 US claimed
EP-0075850-B1 PHARMACEUTICAL PREPARATIONS CONTAINING VICINAL DIHYDROXYALKYL XANTHINES, PROCESS FOR THE PREPARATION OF THE XANTHINES AND THE APPROPRIATE INTERMEDIATES THEREFOR HOECHST AKTIENGESELLSCHAFT (DE) 1985-12-18 EP claimed
US-20220390458-A1 FLUORESCENT PROBE AND APPLICATIONS THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2022-12-08 US disclosed
WO-2021058490-A2 FLUORESCENT PROBE AND APPLICATIONS THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2021-04-01 WO disclosed
EP-3795643-A1 FLUORESCENT PROBE AND APPLICATIONS THEREOF Centre National de la Recherche Scientifique (FR) 2021-03-24 EP disclosed
US-9803030-B2 Modified saccharides GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2017-10-31 US disclosed
EP-2118145-B1 MODIFIED SACCHARIDES GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2017-05-17 EP disclosed
CN-104497154-A Preparation method of hydroxy butyl starch ether or hydroxy butyl modified starch ether UNIV SOUTH CHINA TECH 2015-04-08 CN disclosed
CN-101583629-B Modified saccharides NOVARTIS AG 2013-08-21 CN disclosed
US-RE31512-E SISOMICIN BACTERICIDES BAYER AKTIENGESELLSCHAFT (DE) 1984-01-31 US disclosed
EP-0019843-B1 SISOMICIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINES BAYER AG (DE) 1982-09-29 EP disclosed
US-4312859-A ANTIBIOTICS, BACTERICIDES BAYER AKTIENGESELLSCHAFT (DE) 1982-01-26 US disclosed
EP-0019843-A1 Sisomicin derivatives, process for their preparation and their use as medicines BAYER AG (DE) 1980-12-10 EP disclosed
US-4235888-A SISOMYCIN-TYPE ANTIBIOTICS BAYER AKTIENGESELLSCHAFT (DE) 1980-11-25 US disclosed
EP-0007996-A1 4,6-Di-0-(Aminoglycosyl)-1,3-diaminocyclitols, process for their preparation and pharmaceutical compositions containing them BAYER AG (DE) 1980-02-20 EP disclosed
US-4076632-A PROTONATED DI-POLYETHOXY-MONOALKYL AMINE, UREA THE PROCTER & GAMBLE COMPANY (US) 1978-02-28 US disclosed